Dengli Wang

928 total citations
36 papers, 736 citations indexed

About

Dengli Wang is a scholar working on Clinical Biochemistry, Neurology and Immunology. According to data from OpenAlex, Dengli Wang has authored 36 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Biochemistry, 10 papers in Neurology and 8 papers in Immunology. Recurrent topics in Dengli Wang's work include Advanced Glycation End Products research (17 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Pain Mechanisms and Treatments (5 papers). Dengli Wang is often cited by papers focused on Advanced Glycation End Products research (17 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Pain Mechanisms and Treatments (5 papers). Dengli Wang collaborates with scholars based in Japan, China and Ireland. Dengli Wang's co-authors include Masahiro Nishibori, Hidenori Wake, Keyue Liu, Kiyoshi Teshigawara, Shuji Mori, Daiki Ousaka, Hideo Takahashi, Jun Liang, Lin Cao and Baocheng Cao and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Scientific Reports.

In The Last Decade

Dengli Wang

33 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dengli Wang Japan 15 213 199 169 131 104 36 736
Jui‐Chih Chang Taiwan 21 210 1.0× 907 4.6× 90 0.5× 37 0.3× 117 1.1× 50 1.4k
Maria Cristina Guerra Brazil 13 64 0.3× 536 2.7× 139 0.8× 145 1.1× 116 1.1× 19 978
Yiqin Dai China 14 37 0.2× 245 1.2× 71 0.4× 87 0.7× 48 0.5× 33 702
Yajiang Yuan China 17 31 0.1× 276 1.4× 85 0.5× 38 0.3× 31 0.3× 35 805
Francine Hehn de Oliveira Brazil 14 68 0.3× 243 1.2× 35 0.2× 54 0.4× 32 0.3× 40 535
Jinglin Yi China 17 80 0.4× 311 1.6× 37 0.2× 44 0.3× 17 0.2× 43 803
Yang Huang China 17 35 0.2× 458 2.3× 50 0.3× 51 0.4× 45 0.4× 42 812
Huai Bai China 21 82 0.4× 577 2.9× 32 0.2× 103 0.8× 13 0.1× 99 1.6k
Ramazan Yağcı Türkiye 17 63 0.3× 270 1.4× 38 0.2× 25 0.2× 31 0.3× 68 1.2k
Clive R. Hamlin United States 14 113 0.5× 335 1.7× 129 0.8× 22 0.2× 105 1.0× 30 1.0k

Countries citing papers authored by Dengli Wang

Since Specialization
Citations

This map shows the geographic impact of Dengli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengli Wang more than expected).

Fields of papers citing papers by Dengli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dengli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengli Wang. The network helps show where Dengli Wang may publish in the future.

Co-authorship network of co-authors of Dengli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dengli Wang. A scholar is included among the top collaborators of Dengli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dengli Wang. Dengli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dengli, et al.. (2024). CEO personal experiences and innovation conservatism: Evidence from China. Corporate Governance An International Review. 32(5). 915–932. 2 indexed citations
2.
Wang, Dengli, et al.. (2024). Anti-HMGB1 mAb Therapy Reduces Epidural Hematoma Injury. International Journal of Molecular Sciences. 25(11). 5889–5889.
3.
Takahashi, Yohei, Dengli Wang, Hidenori Wake, et al.. (2024). Antithrombin regulates neutrophil activities through the stimulation of C-type lectin family 1A. PubMed. 2(1). 100032–100032.
4.
Ma, Simeng, Yoki Nakamura, Takahiro Kochi, et al.. (2024). Perineural Treatment with High Mobility Group Box-1 Monoclonal Antibody Prevents Initiation of Pain-Like Behaviors in Female Mice with Trigeminal Neuropathy. Biological and Pharmaceutical Bulletin. 47(1). 221–226. 2 indexed citations
5.
Wang, Dengli, Keyue Liu, Hidenori Wake, et al.. (2023). Protective effects of an anti-4-HNE monoclonal antibody against liver injury and lethality of endotoxemia in mice. European Journal of Pharmacology. 950. 175702–175702. 3 indexed citations
6.
Wang, Dengli, Daiki Ousaka, Ziyi Wang, et al.. (2022). Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb. Cells. 11(19). 2970–2970. 4 indexed citations
7.
Sekiguchi, Fumiko, et al.. (2022). Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies. Journal of Pharmacological Sciences. 148(3). 315–325. 3 indexed citations
8.
Liu, Keyue, et al.. (2022). Histamine induced high mobility group box-1 release from vascular endothelial cells through H1 receptor. Frontiers in Immunology. 13. 930683–930683. 11 indexed citations
9.
Kamiya, Mari, Fumitaka Mizoguchi, Kimito Kawahata, et al.. (2022). Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies. Nature Communications. 13(1). 166–166. 49 indexed citations
10.
Kochi, Takahiro, Yoki Nakamura, Kazue Hisaoka‐Nakashima, et al.. (2021). Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury. Molecules. 26(7). 2035–2035. 19 indexed citations
11.
12.
Nakamura, Yoki, Fang Fang Zhang, Dengli Wang, et al.. (2021). Perineural high-mobility group box 1 induces mechanical hypersensitivity through activation of spinal microglia: Involvement of glutamate-NMDA receptor dependent mechanism in spinal dorsal horn. Biochemical Pharmacology. 186. 114496–114496. 16 indexed citations
13.
Takahashi, Yohei, Hidenori Wake, Masakiyo Sakaguchi, et al.. (2021). Histidine-Rich Glycoprotein Stimulates Human Neutrophil Phagocytosis and Prolongs Survival through CLEC1A. The Journal of Immunology. 206(4). 737–750. 17 indexed citations
14.
Tsubota, Maho, Yusuke Hayashi, Fumiko Sekiguchi, et al.. (2021). Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice. Cells. 10(10). 2550–2550. 9 indexed citations
15.
Sekiguchi, Fumiko, et al.. (2021). Role of neuron-derived ATP in paclitaxel-induced HMGB1 release from macrophages and peripheral neuropathy. Journal of Pharmacological Sciences. 148(1). 156–161. 13 indexed citations
16.
Masai, Kaori, Shinki Murakami, Dengli Wang, et al.. (2021). Neuroprotective Effects of Anti-high Mobility Group Box-1 Monoclonal Antibody Against Methamphetamine-Induced Dopaminergic Neurotoxicity. Neurotoxicity Research. 39(5). 1511–1523. 12 indexed citations
17.
Hisaoka‐Nakashima, Kazue, Yoki Nakamura, Dengli Wang, et al.. (2020). Corticosterone Induces HMGB1 Release in Primary Cultured Rat Cortical Astrocytes: Involvement of Pannexin-1 and P2X7 Receptor-Dependent Mechanisms. Cells. 9(5). 1068–1068. 30 indexed citations
18.
Wang, Dengli, Keyue Liu, Hidenori Wake, et al.. (2017). Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats. Scientific Reports. 7(1). 46243–46243. 86 indexed citations
19.
Teshigawara, Kiyoshi, Yasuko Tomono, Dengli Wang, et al.. (2017). The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets. Journal of Pharmacological Sciences. 134(4). 218–224. 12 indexed citations
20.
Teshigawara, Kiyoshi, Keyue Liu, Dengli Wang, et al.. (2016). Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury. Journal of Pharmacological Sciences. 130(4). 226–234. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jui‐Chih Chang Breakdown of academic impact, for papers by Maria Cristina Guerra Breakdown of academic impact, for papers by Yiqin Dai Breakdown of academic impact, for papers by Yajiang Yuan Breakdown of academic impact, for papers by Francine Hehn de Oliveira Breakdown of academic impact, for papers by Jinglin Yi Breakdown of academic impact, for papers by Yang Huang Breakdown of academic impact, for papers by Huai Bai Breakdown of academic impact, for papers by Ramazan Yağcı Breakdown of academic impact, for papers by Clive R. Hamlin
Rankless by CCL
2026